Report on the Global Immunization Division research program, 2011-2013
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All

Report on the Global Immunization Division research program, 2011-2013

  • Published Date:

    May 2014

  • Language:
Filetype[PDF-2.04 MB]

  • Description:
    Beginning in FY 2011, the Vaccine Preventable Disease Eradication and Elimination Branch (VPDEEB), Global Immunization Division (GID), Centers for Disease Control and Prevention (CDC), established a competitive “request for proposal” mechanism to support polio, measles, rubella, and hepatitis B vaccine research projects that address elimination or eradication issues. ¬The main goals of this branch initiative include building a stronger research program in VPDEEB and establishing new or strengthening current collaborations with international research partners. Each year, VPDEEB scientists submit proposals for potential projects, which are ranked and selected for funding based on the following criteria: • High public health impact • Clear goals and objectives • Strong scientific methods • Realistic plan of action and timeline • Reasonable proposed budget Total funding varies annually based on available resources. ¬This report provides a summary of accomplishments from the first 3 years of this research initiative in context of the Global Vaccine Action Plan (GVAP). Approved by the World Health Assembly in May 2012, the GVAP is a framework to prevent millions of deaths and achieve the Decade of Vaccines’ (DOV) vision of providing universal access to immunization by 2020 and beyond. Th¬e plan includes six strategic objectives toward achievement of the DOV goals. Th¬e sixth objective directly addresses “country, regional, and global research and development innovations that maximize the benefits of immunization.” Research supported by this VPDEEB/GID initiative includes human clinical trials, laboratory studies, vaccine delivery methods testing, innovative surveillance tool evaluations, and economic analyses and have involved numerous partners, including the World Health Organization (WHO), ministries of health, nongovernmental organizations, and academic institutions. CS248057
  • Document Type:
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like: